Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

When is the Lipkin pathogen/gene expression study due out?

Discussion in 'General ME/CFS News' started by Sasha, Sep 22, 2012.

  1. Sasha

    Sasha Fine, thank you

    Messages:
    15,193
    Likes:
    36,912
    UK
    I can't remember if Dr Lipkin mentioned 2013 in the XMRV press conference this week, concerning the big pathogen study - does anyone know when this is due out?

    It's such a mega-study by the sounds of it, and it has at least a couple of aspects - pathogens and gene expression - that I wondered whether it would be published as a single study or come out as a series. In the latter case, we'd get some news faster.

    Does anyone know? If not, please don't email and ask Dr Lipkin, I'd rather he was left alone to get on with the actual research!
     
    SOC and lnester7 like this.
  2. ldhunter

    ldhunter

    Messages:
    26
    Likes:
    5
    I was told 'hopefully'next year.
     
    JAH likes this.

See more popular forum discussions.

Share This Page